Related Experiment Video
Updated: Jan 24, 2026

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1α in NRVMs
Zuheng Liu1,2, Haiping Tian1,2,3, Jinghai Hua1,2
1State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Abstract:
Chromosomal maintenance 1 (CRM1) inhibitors display antihypertrophic effects and control protein trafficking between the nucleus and the cytoplasm. PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1alpha) is a type of transcriptional coactivator that predominantly resides in the nucleus and is downregulated during heart failure. NT-PGC-1α is an alternative splicing variant of PGC-1α that is primarily distributed in the cytoplasm. We hypothesized that the use of a CRM1 inhibitor could shuttle NT-PGC-1α into the nucleus and activate PGC-1α target genes to potentially improve cardiac function in a mouse model of myocardial infarction (MI). We showed that PGC-1α and NT-PGC-1α were decreased in MI-induced heart failure mice. Phenylephrine and angiotensin II were applied to induce hypertrophy in neonatal rat ventricular myocytes (NRVMs). The antihypertrophic effects of the CRM1-inhibitor Selinexor was verified through profiling the expression of β-MHC and through visualizing the cell cross-sectional area. NRVMs were transfected with adenovirus-NT-PGC-1α or adenovirus-NLS (nucleus localization sequence)-NT-PGC-1α and then exposed to Selinexor. Confocal microscopy was then used to observe the shuttling of NT-PGC-1α. After NT-PGC-1α was shuttled into the nucleus, there was increased expression of its related genes, including PPAR-α, Tfam, ERR-γ, CPT1b, PDK4, and Nrf2. The effects of Selinexor on post-MI C57BL/6j mice were determined by echocardiography and qPCR. We found that Selinexor showed antihypertrophic effects but did not influence the ejection fraction of MI-mice. Interestingly, the antihypertrophic effects of Selinexor might be independent of NT-PGC-1α transportation.
Insights
Chromosomal maintenance 1 (CRM1) inhibitors like Selinexor reduced heart cell size but did not improve heart function in mice after myocardial infarction. The antihypertrophic effects may not depend on shuttling NT-PGC-1α into the nucleus.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Cellular Signaling
Background:
- Chromosomal maintenance 1 (CRM1) inhibitors impact protein trafficking and have shown antihypertrophic effects.
- Peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1α) is crucial for cardiac function and downregulated in heart failure.
- NT-PGC-1α, a cytoplasmic variant, was investigated for nuclear translocation and potential therapeutic roles.
Purpose of the Study:
- To investigate if CRM1 inhibition could shuttle NT-PGC-1α into the nucleus and activate target genes, potentially improving cardiac function post-myocardial infarction (MI).
- To evaluate the antihypertrophic effects of the CRM1 inhibitor Selinexor in cellular and animal models of heart failure.
Main Methods:
- Induced cardiac hypertrophy in neonatal rat ventricular myocytes (NRVMs) using phenylephrine and angiotensin II.
- Treated NRVMs with Selinexor and assessed antihypertrophic effects via β-MHC expression and cell size.
- Utilized confocal microscopy to observe NT-PGC-1α shuttling in transfected NRVMs.
- Administered Selinexor to C57BL/6j mice post-MI and evaluated cardiac function using echocardiography and gene expression via qPCR.
Main Results:
- PGC-1α and NT-PGC-1α levels were decreased in mice with MI-induced heart failure.
- Selinexor demonstrated antihypertrophic effects in NRVMs, reducing cell size and β-MHC expression.
- Nuclear translocation of NT-PGC-1α led to increased expression of target genes (PPAR-α, Tfam, ERR-γ, CPT1b, PDK4, Nrf2).
- In post-MI mice, Selinexor reduced hypertrophy but did not improve ejection fraction.
Conclusions:
- Selinexor exhibits antihypertrophic properties in cardiac cells and models of heart failure.
- The observed antihypertrophic effects of Selinexor in post-MI mice may occur independently of NT-PGC-1α nuclear transport.
- Further research is needed to elucidate the precise mechanisms underlying Selinexor's effects on cardiac hypertrophy.
More Related Videos
09:24O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
06:51Isolation and Culture of Adult Mouse Cardiomyocytes for Cell Signaling and in vitro Cardiac Hypertrophy
Published on: May 21, 2014
Related Concept Videos
Atomic Nuclei: Nuclear Spin State Population Distribution
Nuclear Power
Nuclear Fuels
Nuclear fuel consists of a fissile isotope, such as uranium-235, which must be present in sufficient quantity to provide a...
Nuclear Stability
To hold positively charged protons together...
Nuclear Transmutation
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Non-nuclear Inheritance